The L-type amino acid transporter (LAT1) is a uniporter that mediates the transport of neutral amino acids like L-tryptophan, leucine, histidine, proline, alanine, etc. LAT1 favors the transport of amino acids with large branched or aromatic side chains. The amino acid transporter functions to move essential amino acids into the intestinal epithelium, placenta, and blood-brain barrier for cellular processes such as metabolism and cell signaling. The transporter is of particular significance in the central nervous system as it provides the necessary amino acids for protein synthesis and neurotransmitter production in brain cells. Aromatic amino acids like phenylalanine and tryptophan are precursors for neurotransmitters like dopamine, serotonin, and norepinephrine.
LAT1 is a membrane protein of the SLC7 family of transporters and works in conjunction with the SLC3 family member 4F2hc to form a heterodimeric complex known as the 4F2hc complex. The heterodimer consists of a light chain and a heavy chain covalently bonded by a disulfide bond. The light chain is the one that carries out transport, while the heavy chain is needed to stabilize the dimer.
There is some controversy over whether LAT1 is an uniporter or an antiporter. The transporter has uniporter characteristics of transporting amino acids into cells in a unidirectional manner down the concentration gradient. However, recently it has been found that the transporter has antiporter characteristics of exchanging neutral amino acids for abundant intracellular amino acids.  Over-expression of LAT1 has been found in human cancer and is associated with playing a role in cancer metabolism.